Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
vlamanchev vlamanchev Amateur
Feb 6, 2025 Bullish $192.97 V 1
Jan 14, 2025 $178.11 +0.78% $175.55 X 98.54% 1
Jan 14, 2025 $177.60 +0.49% $175.55 X 98.83% 1
Nov 25, 2024 $175.03 -1.09% $177.05 X 98.86% 1
Nov 25, 2024 $175.74 -0.68% $177.05 X 99.26% 3
Nov 25, 2024 Bullish $177.05 V 1
Aug 16, 2024 $191.75 -0.85% $193.90 X 98.89% 1
Aug 16, 2024 $192.37 -0.53% $193.90 X 99.21% 2
Jun 20, 2024 $170.10 -0.74% $172.13 X 98.82% 1
Jun 20, 2024 $170.57 -0.46% $172.13 X 99.09% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE